Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+T-Cell Epitopes
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
A double-blind randomized phase I trial was conducted in human immunodeficiency virus type 1 (HIV-1)-negative subjects receiving vaccines vectored by plasmid DNA and modified vaccinia virus Ankara (MVA) expressing HIV-1 p24/p17 gag linked to a string of CD8+T-cell epitopes. The trial had two groups. One group received either two doses of MVA.HIVA (2× MVA.HIVA) (n= 8) or two doses of placebo (2× placebo) (n= 4). The second group received 2× pTHr.HIVA followed by one dose of MVA.HIVA (n= 8) or 3× placebo (n= 4). In the pTHr.HIVA-MVA.HIVA group, HIV-1-specific T-cell responses peaked 1 week after MVA.HIVA vaccination in both ex vivo gamma interferon (IFN-γ) ELISPOT (group mean, 210 spot-forming cells/10 6 cells) and proliferation (group mean stimulation index, 37), with assays detecting positive responses in four out of eight and five out of eight subjects, respectively. No HIV-1-specific T-cell responses were detected in either assay in the 2× MVA.HIVA group or subjects receiving placebo. Using a highly sensitive and reproducible cultured IFN-γ ELISPOT assay, positive responses mainly mediated by CD4+T cells were detected in eight out of eight vaccinees in the pTHr.HIVA-MVA.HIVA group and four out of eight vaccinees in the 2× MVA.HIVA group. Importantly, no false-positive responses were detected in the eight subjects receiving placebo. Of the 12 responders, 11 developed responses to previously identified immunodominant CD4+T-cell epitopes, with 6 volunteers having responses to more than one epitope. Five out of 12 responders also developed CD8+T-cell responses to the epitope string. Induced T cells produced a variety of anti-viral cytokines, including tumor necrosis factor alpha and macrophage inflammatory protein 1β. These data demonstrate that prime-boost vaccination with recombinant DNA and MVA vectors can induce multifunctional HIV-1-specific T cells in the majority of vaccinees.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495 · cited 1×
“viremia is associated with the detection and expansion of virusspecific CD8 T cells prior to the detection of neutralizing antibodies (10, 38, 54).”
BackgroundBorrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M., & Oldstone, M. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.6103-6110.1994 · Cited by 1,882 · cited 1×
“viremia is associated with the detection and expansion of virusspecific CD8 T cells prior to the detection of neutralizing antibodies (10, 38, 54).”
BackgroundVigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,835 · cited 1×
“Studies comparing the phenotype and function of T cells in patients with either progressive or nonprogressive HIV-1 disease have described differences in CD4 and CD8 T-cell proliferation (58, 62), production of cytokines (28), expression of memory and activation markers (16), and production of cytolytic (4) and noncyt…”
Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,407 · cited 1×
“Depletion of CD8 T cells prior to challenge increased susceptibility of macaques to infection with simian immunodeficiency virus (34).”
BackgroundQuantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA
Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., et al. (1998) · Science · doi:10.1126/science.279.5359.2103 · Cited by 1,383 · cited 1×
“viremia is associated with the detection and expansion of virusspecific CD8 T cells prior to the detection of neutralizing antibodies (10, 38, 54).”
BackgroundSelf-citationMascola, J. R., Stiegler, G., VanCott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E., Beary, H., Hayes, D., Frankel, S. S., Birx, D. L., et al. (2000) · Nature Medicine · doi:10.1038/72318 · Cited by 1,250
HLA and HIV-1: Heterozygote Advantage and B*35-Cw*04 Disadvantage
Carrington, M., Nelson, G. W., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R., Buchbinder, S., Hoots, K., & O'Brien, S. J. (1999) · Science · doi:10.1126/science.283.5408.1748 · Cited by 1,224
Shiver, J. W., Fu, T.-M., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z.-Q., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,176
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., Rothbard, J. A., Bangham, C. R. M., Rizza, C. R., et al. (1991) · Nature · doi:10.1038/354453a0 · Cited by 1,015 · cited 1×
“Examples of CD8 T-cell viral escape mutants and, more recently, emergence of an escape mutant prior to viral rebound has also been described in human HIV-1 infection (55, 57).”
BackgroundSelf-citationSkewed maturation of memory HIV-specific CD8 T lymphocytes
Champagne, P., Ogg, G. S., King, A. S., Knabenhans, C., Ellefsen, K., Nobile, M., Appay, V., Rizzardi, G. P., Fleury, S., Lipp, M., et al. (2001) · Nature · doi:10.1038/35065118 · Cited by 1,004 · cited 1×
“Studies comparing the phenotype and function of T cells in patients with either progressive or nonprogressive HIV-1 disease have described differences in CD4 and CD8 T-cell proliferation (58, 62), production of cytokines (28), expression of memory and activation markers (16), and production of cytolytic (4) and noncyt…”
Self-citationMigueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W., Selig, S. M., Schwartz, D., Sullivan, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050567397 · Cited by 995
CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication
Walker, C. M., Moody, D. J., Stites, D. P., & Levy, J. A. (1986) · Science · doi:10.1126/science.2431484 · Cited by 990 · cited 1×
“Supernatants from HIV-1-specific CD4 T-cell cultures showed a significant association between the production of IFN- and several other cytokines, including TNF- , MIP1 , and GM-CSF, previously shown to have antiviral functions (17, 29, 42, 72, 76).”
BackgroundKaslow, R. A., Carrington, M., Apple, R., Park, L., Muñoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J., Rinaldo, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0496-405 · Cited by 970
Barouch, D. H., Santra, S., Schmitz, J. E., Kuroda, M. J., Fu, T.-M., Wagner, W., Bilska, M., Craiu, A., Zheng, X. X., Krivulka, G. R., et al. (2000) · Science · doi:10.1126/science.290.5491.486 · Cited by 881
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function
Appay, V., Nixon, D. F., Donahoe, S. M., Gillespie, G. M. A., Dong, T., King, A., Ogg, G. S., Spiegel, H. M. L., Conlon, C., Spina, C. A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.63 · Cited by 871 · cited 1×
“Studies comparing the phenotype and function of T cells in patients with either progressive or nonprogressive HIV-1 disease have described differences in CD4 and CD8 T-cell proliferation (58, 62), production of cytokines (28), expression of memory and activation markers (16), and production of cytolytic (4) and noncyt…”
Self-citationPitcher, C. J., Quittner, C., Peterson, D. M., Connors, M., Koup, R. A., Maino, V. C., & Picker, L. J. (1999) · Nature Medicine · doi:10.1038/8400 · Cited by 746 · cited 1×
“Studies comparing the phenotype and function of T cells in patients with either progressive or nonprogressive HIV-1 disease have described differences in CD4 and CD8 T-cell proliferation (58, 62), production of cytokines (28), expression of memory and activation markers (16), and production of cytolytic (4) and noncyt…”
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
Rowland-Jones, S., Sutton, J., Ariyoshi, K., Dong, T., Gotch, F., McAdam, S., Whitby, D., Sabally, S., Gallimore, A., Corrah, T., et al. (1995) · Nature Medicine · doi:10.1038/nm0195-59 · Cited by 740
Self-citationPersistence of Memory CD8 T Cells in MHC Class I-Deficient Mice
Murali-Krishna, K., Lau, L. L., Sambhara, S., Lemonnier, F., Altman, J., & Ahmed, R. (1999) · Science · doi:10.1126/science.286.5443.1377 · Cited by 725 · cited 1×
“Adoptive transfer and gene deletion studies in mice have shown that memory T cells can mediate protection from viral infection in the absence of antigen (32, 39, 50, 77).”
BackgroundBetts, M. R., Ambrozak, D. R., Douek, D. C., Bonhoeffer, S., Brenchley, J. M., Casazza, J. P., Koup, R. A., & Picker, L. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.11983-11991.2001 · Cited by 689 · cited 1×
“HIV-1-specific effector T cells correlated with viral load (1, 9).”
BackgroundAddo, M. M., Yu, X. G., Rathod, A., Cohen, D., Eldridge, R. L., Strick, D., Johnston, M. N., Corcoran, C., Wurcel, A. G., Fitzpatrick, C. A., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.2081-2092.2003 · Cited by 669
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
Barouch, D. H., Kunstman, J., Kuroda, M. J., Schmitz, J. E., Santra, S., Peyerl, F. W., Krivulka, G. R., Beaudry, K., Lifton, M. A., Gorgone, D. A., et al. (2002) · Nature · doi:10.1038/415335a · Cited by 661 · cited 1×
“Despite the achievement of vaccine-induced protection in nonhuman primates, in one animal protection was lost when a mutation occurred in a single immundominant CD8 T-cell epitope, demonstrating that following infection CD8 T cells exert pressure on viral selection (5).”
BackgroundCytotoxic T-cell memory without antigen
Lau, L. L., Jamieson, B. D., Somasundaram, T., & Ahmed, R. (1994) · Nature · doi:10.1038/369648a0 · Cited by 656 · cited 1×
“Adoptive transfer and gene deletion studies in mice have shown that memory T cells can mediate protection from viral infection in the absence of antigen (32, 39, 50, 77).”
BackgroundSun, J. C., Williams, M. A., & Bevan, M. J. (2004) · Nature Immunology · doi:10.1038/ni1105 · Cited by 649 · cited 1×
“The induction of multifunctional and strongly proliferative CD4 T cells is important for the maintenance of functional CD8 T cells (68).”
BackgroundSchneider, J., Gilbert, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., Becker, M., Sinden, R., Smith, G. L., & Hill, A. V. S. (1998) · Nature Medicine · doi:10.1038/nm0498-397 · Cited by 644
Self-citationMacGregor, R. R., Boyer, J. D., Ugen, K. E., Lacy, K. E., Gluckman, S. J., Bagarazzi, M. L., Chattergoon, M. A., Baine, Y., Higgins, T. J., Ciccarelli, R. B., et al. (1998) · Journal of Infectious Diseases · doi:10.1086/515613 · Cited by 640 · cited 1×
“Vaccines so far tested have included recombinant DNA, MVA, canary pox, and lipopeptides (11, 14, 23, 41, 51, 52).”
BackgroundMcShane, H., Pathan, A. A., Sander, C. R., Keating, S. M., Gilbert, S. C., Huygen, K., Fletcher, H. A., & Hill, A. V. S. (2004) · Nature Medicine · doi:10.1038/nm1128 · Cited by 570 · cited 1×
“delivery in humans (45, 46) are more consistent with results”
ResultMcConkey, S. J., Reece, W. H. H., Moorthy, V. S., Webster, D., Dunachie, S., Butcher, G., Vuola, J. M., Blanchard, T. J., Gothard, P., Watkins, K., et al. (2003) · Nature Medicine · doi:10.1038/nm881 · Cited by 553
Virus-specific CD8+ T-cell memory determined by clonal burst size
Hou, S., Hyland, L., Ryan, K. W., Portner, A., & Doherty, P. C. (1994) · Nature · doi:10.1038/369652a0 · Cited by 514 · cited 1×
“Adoptive transfer and gene deletion studies in mice have shown that memory T cells can mediate protection from viral infection in the absence of antigen (32, 39, 50, 77).”
BackgroundTrkola, A., Kuster, H., Rusert, P., Joos, B., Fischer, M., Leemann, C., Manrique, A., Huber, M., Rehr, M., Oxenius, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1244 · Cited by 502
Pantaleo, G., & Koup, R. A. (2004) · Nature Medicine · doi:10.1038/nm0804-806 · Cited by 444 · cited 1×
“Together these reports suggest that a protective T-cell response to HIV-1 infection may involve different subpopulations of multifunctional T cells (56).”
BackgroundRichman, D., Shih, C. K., Lowy, I., Rose, J., Prodanovich, P., Goff, S., & Griffin, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11241 · Cited by 393
Robinson, H. L., Montefiori, D. C., Johnson, R. P., Manson, K. H., Kalish, M. L., Lifson, J. D., Rizvi, T. A., Lü, S., Hu, S.-L., Mazzara, G. P., et al. (1999) · Nature Medicine · doi:10.1038/8406 · Cited by 387
Harari, A., Petitpierre, S., Vallelian, F., & Pantaleo, G. (2004) · Blood · doi:10.1182/blood-2003-04-1203 · Cited by 378 · cited 1×
“Studies comparing the phenotype and function of T cells in patients with either progressive or nonprogressive HIV-1 disease have described differences in CD4 and CD8 T-cell proliferation (58, 62), production of cytokines (28), expression of memory and activation markers (16), and production of cytolytic (4) and noncyt…”
Goonetilleke, N. P., McShane, H., Hannan, C. M., Anderson, R. J., Brookes, R. H., & Hill, A. V. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1602 · Cited by 360
Self-citationCurrier, J. R., Kuta, E. G., Turk, E., Earhart, L. B., Loomis-Price, L., Janetzki, S., Ferrari, G., Birx, D. L., & Cox, J. H. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00535-x · Cited by 320 · cited 1×
“and cytomegalovirus CD8 T-cell epitopes (20).”
Reece, W. H. H., Pinder, M., Gothard, P. K., Milligan, P., Bojang, K., Doherty, T., Plebanski, M., Akinwunmi, P., Everaere, S., Watkins, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1009 · Cited by 264 · cited 1×
“Two recent studies in malaria have shown that T-cell responses detected by IFN- -cultured IFN- ELISPOT protocols but not ex vivo IFN- ELISPOT assays correlated with protection from malaria; first, against natural infection in field trials in The Gambia, and second, against controlled malaria challenge in healthy subje…”
BackgroundMwau, M., Cebere, I., Sutton, J., Chikoti, P., Winstone, N., Wee, E. G.-T., Beattie, T., Chen, Y.-H., Dorrell, L., McShane, H., et al. (2004) · Journal of General Virology · doi:10.1099/vir.0.19701-0 · Cited by 207 · cited 2×
“(Anaspec, San Jose, CA) described previously (52, 53).”
BackgroundSelf-citationProspects for Vaccine Protection Against HIV-1 Infection and AIDS
Letvin, N. L., Barouch, D. H., & Montefiori, D. C. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.094854 · Cited by 179
Kaufmann, D. E., Bailey, P. M., Sidney, J., Wagner, B., Norris, P. J., Johnston, M. N., Cosimi, L. A., Addo, M. M., Lichterfeld, M., Altfeld, M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4463-4477.2004 · Cited by 178 · cited 2×
“HIVA corresponded to previously defined immunodominant CD4 T-cell epitopes capable of promiscuous binding to multiple HLA-DR alleles identified in HIV-1-infected patients and are listed in Table 5 (36).”
BackgroundMancini-Bourgine, M., Fontaine, H., Scott-Algara, D., Pol, S., Bréchot, C., & Michel, M.-L. (2004) · Hepatology · doi:10.1002/hep.1840400417 · Cited by 178
Boyer, J., Cohen, A. D., Vogt, S., Schumann, K., Nath, B., Ahn, L., Lacy, K. E., Bagarazzi, M. L., Higgins, T. J., Baine, Y., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315229 · Cited by 168 · cited 1×
“Vaccines so far tested have included recombinant DNA, MVA, canary pox, and lipopeptides (11, 14, 23, 41, 51, 52).”
BackgroundCD8+ T-cell selection, function, and death in the primary immune response in vivo
Callan, M. F. C., Fazou, C., Yang, H., Rostron, T., Poon, K., Hatton, C., & McMichael, A. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10590 · Cited by 158 · cited 1×
“been shown to rescue cells from apoptotic death (13), and from preliminary experiments we confirmed a previous report that the addition of IL-7–IL-15 increased the frequency of response the ex vivo IFN- ELISPOT (33 and data not shown).”
ResultSelf-citationKeating, S. M., Bejon, P., Berthoud, T. K., Vuola, J. M., Todryk, S. M., Webster, D. P., Dunachie, S. J., Moorthy, V., McConkey, S. J., Gilbert, S. C., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5675 · Cited by 146
Wong, G. H., Krowka, J. F., Stites, D. P., & Goeddel, D. V. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.1.120 · Cited by 136 · cited 1×
“Supernatants from HIV-1-specific CD4 T-cell cultures showed a significant association between the production of IFN- and several other cytokines, including TNF- , MIP1 , and GM-CSF, previously shown to have antiviral functions (17, 29, 42, 72, 76).”
BackgroundGenetic Subtypes, Humoral Immunity, and Human Immunodeficiency Virus Type 1 Vaccine Development
Moore, J. P., Parren, P. W. H. I., & Burton, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.5721-5729.2001 · Cited by 134 · cited 1×
“if neutralizing (48), require the induction of high titers difficult”
BackgroundControl of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
Amara, R. R., Villinger, F., Altman, J. D., Lydy, S. L., O'Neil, S. P., Staprans, S. I., Montefiori, D. C., Xu, Y., Herndon, J. G., Wyatt, L. S., et al. (2001) · Science · doi:10.1126/science.292.5514.69 · Cited by 133 · cited 1×
“Subsequent studies showed that the induction of high frequencies of T cells in macaques following vaccination with various T-cell vaccines lowered viremia in animals challenged with the highly aggressive SHIV.89.6P strain ( 2 , 7, 61, 66).”
BackgroundCosma, A., Nagaraj, R., Bühler, S., Hinkula, J., Busch, D. H., Sutter, G., Goebel, F. D., & Erfle, V. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00538-3 · Cited by 124
Control of HIV-1 infection by soluble factors of the immune response
DeVico, A. L., & Gallo, R. C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro878 · Cited by 115
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses
Barouch, D. H., Letvin, N. L., & Seder, R. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00200.x · Cited by 106
On Immunity Against Infections and Vaccines: Credo 2004
Zinkernagel, R. M., & Hengartner, H. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01460.x · Cited by 97 · cited 1×
“Adoptive transfer and gene deletion studies in mice have shown that memory T cells can mediate protection from viral infection in the absence of antigen (32, 39, 50, 77).”
BackgroundCalarota, S. A., & Weiner, D. B. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00150.x · Cited by 96
Wang, R., Epstein, J. E., Charoenvit, Y., Baraceros, M. F. B., Rahardjo, N., Gay, T., Banania, J.-G., Chattopadhyay, R., Vega, P. D. L., Richie, T. L., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5561 · Cited by 96
Moorthy, V., Pinder, M., Reece, W. H. H., Watkins, K., Atabani, S. F., Hannan, C. M., Bojang, K., McAdam, K. P. W. J., Schneider, J., Gilbert, S. C., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/378515 · Cited by 96 · cited 2×
“Consistent with other published clinical vaccine studies, the DNA/MVA vaccination regimen employed in this study induced predominately CD4 T-cell responses to the expressed protein (49, 71).”
BackgroundResultBertley, F. M. N., Kozlowski, P. A., Wang, S.-W., Chappelle, J., Patel, J. G., Sonuyi, O., Mazzara, G. P., Montefiori, D. C., Carville, A., Mansfield, K. G., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3745 · Cited by 93 · cited 1×
“using different routes of delivery (8) or delivering DNA vac-”
MethodCOPLAN, P. M., Gupta, S. B., Dubey, S. A., Pitisuttithum, P., Nikas, A. A., Mbewe, B., Vardas, E., Schechter, M., Kallas, E. G., Freed, D., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428450 · Cited by 89
Smith, C. S., Dunbar, P. R., Mirza, F., Palmowski, M. J., Shepherd, D., Gilbert, S. C., Coulie, P. G., Schneider, J., Hoffman, E. W., Hawkins, R. E., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20569 · Cited by 86 · cited 1×
“These data further support the previously reported observation (67) that CD8 T-cell epitopes separated by short linker sequences and not in the context of the native protein can be processed and presented in vivo.”
ResultSelf-citationDorrell, L., Yang, H., Ondondo, B., Dong, T., di Gleria, K., Suttill, A., Conlon, C. P., Brown, D., Williams, P., Bowness, P., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4705-4716.2006 · Cited by 86
Self-citationGahéry-Ségard, H., Pialoux, G., Figueiredo, S., Igéa, C., Surenaud, M., Gaston, J., Gras-Masse, H., Lévy, J.-P., & Guillet, J.-G. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11220-11231.2003 · Cited by 76
Development of a DNA-MVA/HIVA vaccine for Kenya
Hanke, T., McMichael, A. J., Mwau, M., Wee, E. G., Ceberej, I., Patel, S. P., Sutton, J., Tomlinson, M., & Samuel, R. V. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00085-3 · Cited by 75 · cited 2×
“Immunogenicity studies using these vectors in rodents and macaques elicited high frequencies of CD8 T cells after vaccination (27, 74).”
BackgroundSelf-citationMwau, M., McMichael, A. J., & Hanke, T. (2002) · AIDS Research and Human Retroviruses · doi:10.1089/088922202760019301 · Cited by 73 · cited 1×
“(Anaspec, San Jose, CA) described previously (52, 53).”
Self-citationOxenius, A., Price, D. A., Trkola, A., Edwards, C., Emma Gostick, D., Zhang, H., Easterbrook, P., Tun, T., Johnson, A., Waters, A., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/422760 · Cited by 71 · cited 1×
“Examples of CD8 T-cell viral escape mutants and, more recently, emergence of an escape mutant prior to viral rebound has also been described in human HIV-1 infection (55, 57).”
BackgroundCao, H., Kaleebu, P., Hom, D. L., Flores, J., Agrawal, D., Jones, N. G., Serwanga, J., Okello, M., Walker, C., Sheppard, H., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/368020 · Cited by 68
Hofmann‐Lehmann, R., Rasmussen, R. A., Vlasak, J., Smith, B. A., Baba, T. W., Liška, V., Montefiori, D. C., McClure, H. M., Anderson, D. C., Bernacky, B. J., et al. (2001) · Journal of Medical Primatology · doi:10.1034/j.1600-0684.2001.d01-52.x · Cited by 39
Cited by
Goonetilleke, N., Liu, M. K. P., Salazar-Gonzalez, J. F., Ferrari, G., Giorgi, E., Ganusov, V. V., Keele, B. F., Learn, G. H., Turnbull, E. L., Salazar, M. G., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090365 · Cited by 641
Self-citationNanotechnology in vaccine delivery
Peek, L. J., Middaugh, C. R., & Berkland, C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.017 · Cited by 562
DNA vaccines: an historical perspective and view to the future
Liu, M. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00980.x · Cited by 468
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
Létourneau, S., Im, E.-J., Mashishi, T., Brereton, C., Bridgeman, A., Yang, H., Dorrell, L., Dong, T., Korber, B., McMichael, A. J., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000984 · Cited by 281
Self-citationHayward, A. C., Wang, L., Goonetilleke, N., Fragaszy, E. B., Bermingham, A., Copas, A., Dukes, O., Millett, E. R. C., Nazareth, I., Nguyen-Van-Tam, J. S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201411-1988oc · Cited by 266
Self-citation
Metadata
- Authors
- Goonetilleke, N., Moore, S., Dally, L., Winstone, N., Cebere, I., Mahmoud, A., Pinheiro, S., Gillespie, G., Brown, D., Loach, V., Roberts, J., Guimaraes-Walker, A., Hayes, P., Loughran, K., Smith, C., De Bont, J., Verlinde, C., Vooijs, D., Schmidt, C., Boaz, M., Gilmour, J., Fast, P., Dorrell, L., Hanke, T., & McMichael, A. J.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-05-15
- Volume
- 80
- Issue
- 10
- Pages
- 4717-4728
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2105323221
- Cited by
- 236
- References
- 65
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.